ClinicalTrials.gov record
Recruiting Phase 3 Interventional

Study of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003)

ClinicalTrials.gov ID: NCT06136624

Public ClinicalTrials.gov record NCT06136624. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 8, 2026, 8:10 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3 Randomized, Open-label Study of MK-5684 Versus Alternative Abiraterone Acetate or Enzalutamide in Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) Previously Treated With Next-generation Hormonal Agent (NHA) and Taxane-based Chemotherapy (OMAHA-003)

Study identification

NCT ID
NCT06136624
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Merck Sharp & Dohme LLC
Industry
Enrollment
1,310 participants

Conditions and interventions

Interventions

  • Abiraterone acetate Drug
  • Dexamethasone Drug
  • Enzalutamide Drug
  • Fludrocortisone acetate Drug
  • Hydrocortisone Drug
  • Opevesostat Drug
  • Prednisone Drug

Drug

Eligibility (public fields only)

Age range
Not listed
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 30, 2023
Primary completion
Aug 1, 2028
Completion
Feb 14, 2030
Last update posted
May 4, 2026

2023 – 2030

United States locations

U.S. sites
44
U.S. states
26
U.S. cities
40
Facility City State ZIP Site status
University of California, Irvine (UCI) Health - UC Irvine Medical Center ( Site 0040) Orange California 92868 Active, not recruiting
Stanford Cancer Center ( Site 0036) Palo Alto California 94304 Recruiting
Kaiser Permanente Riverside Medical Center ( Site 0099) Riverside California 92505 Recruiting
Anschutz Cancer Pavilion ( Site 0046) Aurora Colorado 80045 Recruiting
University of Colorado Health - Highlands Ranch Hospital ( Site 0111) Highlands Ranch Colorado 80129 Recruiting
Colorado Clinical Research ( Site 0067) Lakewood Colorado 80228 Active, not recruiting
University of Colorado Health - Lone Tree Medical Center ( Site 0112) Lone Tree Colorado 80124 Recruiting
Yale-New Haven Hospital-Yale Cancer Center ( Site 0064) New Haven Connecticut 06510 Recruiting
Florida Cancer Specialists - South ( Site 7003) Fort Myers Florida 33901 Recruiting
Bruce W. Carter Veterans Affairs Medical Center ( Site 0082) Miami Florida 33125 Active, not recruiting
University of Miami Hospital and Clinics, Sylvester Cancer Center ( Site 0051) Miami Florida 33136 Recruiting
University of Illinois at Chicago ( Site 0105) Chicago Illinois 60612 Recruiting
University of Chicago Medical Center ( Site 0045) Chicago Illinois 60637 Recruiting
University of Iowa ( Site 0047) Iowa City Iowa 52242 Recruiting
University of Kentucky Chandler Medical Center ( Site 0048) Lexington Kentucky 40536 Active, not recruiting
Ochsner Clinic Foundation ( Site 0108) New Orleans Louisiana 70121 Active, not recruiting
Baltimore Veterans Affairs Medical Center ( Site 0069) Baltimore Maryland 21201 Recruiting
Greenebaum Comprehensive Cancer Center ( Site 0049) Baltimore Maryland 21201 Recruiting
Henry Ford Hospital ( Site 0015) Detroit Michigan 48202 Active, not recruiting
M Health Fairview Clinics and Surgery Center ( Site 0019) Minneapolis Minnesota 55455 Recruiting
Metro-Minnesota Community Clinical Oncology ( Site 0014) Saint Louis Park Minnesota 55416 Recruiting
Washington University School of Medicine-Internal Medicine/Oncology ( Site 0062) St Louis Missouri 63110 Active, not recruiting
University Of Nebraska Medical Center-Oncology/Hematology ( Site 0095) Omaha Nebraska 68105 Recruiting
Comprehensive Cancer Centers of Nevada ( Site 0010) Las Vegas Nevada 89148 Recruiting
Atlantic Health System Morristown Medical Center ( Site 0115) Morristown New Jersey 07960 Recruiting
Rutgers Cancer Institute of New Jersey ( Site 0033) New Brunswick New Jersey 08901 Active, not recruiting
James J. Peters VA Medical Center ( Site 0088) The Bronx New York 10468 Recruiting
University Hospitals Cleveland Medical Center ( Site 0043) Cleveland Ohio 44106 Recruiting
Oregon Health and Science University ( Site 0028) Portland Oregon 97239 Active, not recruiting
VA Portland Health Care System ( Site 0058) Portland Oregon 97239 Recruiting
AHN Allegheny General Hospital ( Site 0001) Pittsburgh Pennsylvania 15212 Active, not recruiting
Ralph H. Johnson VA Health Care System (RHJVAHCS)-Urology ( Site 0083) Charleston South Carolina 29401 Active, not recruiting
Avera Cancer Institute - Pierre ( Site 0118) Pierre South Dakota 57501 Recruiting
Avera Cancer Institute- Research ( Site 0094) Sioux Falls South Dakota 57105 Recruiting
Avera Cancer Institute - Yankton ( Site 0117) Yankton South Dakota 57078 Recruiting
SCRI Oncology Partners ( Site 7000) Nashville Tennessee 37203 Recruiting
Texas Oncology - Central/South Texas ( Site 8003) Austin Texas 78731 Recruiting
Texas Oncology - DFW ( Site 8001) Dallas Texas 75246 Active, not recruiting
Texas Oncology - Gulf Coast ( Site 8002) The Woodlands Texas 77380 Recruiting
University of Virginia Health System ( Site 0054) Charlottesville Virginia 22908 Recruiting
VCU Health Adult Outpatient Pavillion ( Site 0061) Richmond Virginia 23219 Active, not recruiting
Blue Ridge Cancer Care ( Site 0004) Roanoke Virginia 24014 Recruiting
Fred Hutchinson Cancer Center ( Site 0013) Seattle Washington 98109 Recruiting
MEDICAL COLLEGE OF WISCONSIN ( Site 0020) Milwaukee Wisconsin 53226 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 238 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06136624, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 4, 2026 · Synced May 8, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06136624 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →